Audiometric characteristics of a Dutch family linked to DFNA15 with a novel mutation (p.L289F) in POU4F3

Archives of Otolaryngology - Head and Neck Surgery

Volumn 134, Issue 3, 2008, Pages 294-300

  Pauw, Robert J ^a   Van Drunen, F J Wendy ^a   Collin, Rob W J ^a   Huygen, Patrick L M ^a   Kremer, Hannie ^a   Cremers, Cor W R J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; AUDIOMETRY; AUTOSOMAL DOMINANT INHERITANCE; CHILD; FAMILY; GENE; GENE MUTATION; HEARING; HUMAN; MAJOR CLINICAL STUDY; PEDIGREE; PERCEPTION DEAFNESS; POU4F3 GENE; PRESBYACUSIS; PURE TONE AUDIOMETRY; SPEECH AUDIOMETRY; VESTIBULAR DISORDER; VESTIBULAR LABYRINTH HYPOFUNCTION; VESTIBULAR TEST;

ADULT; AGED; AUDIOMETRY, PURE-TONE; AUDIOMETRY, SPEECH; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; GENES, DOMINANT; HEARING LOSS, SENSORINEURAL; HOMEODOMAIN PROTEINS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MUTATION; NETHERLANDS; PEDIGREE; REGRESSION ANALYSIS; TRANSCRIPTION FACTOR BRN-3C;

EID: 41149115645     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archotol.134.3.294     Document Type: Article

References (30)

1. Van Camp G, Smith RJH. Hereditary hearing loss homepage. http://webh01.ua.ac.be/hhh/. Accessed February 2007.
2. Vahava O, Morell R, Lynch ED, et al. Mutation in transcription factor POU4F3 associated with inherited progressive hearing loss in humans. Science. 1998; 279(5358):1950-1954.
3. Frydman M, Vreugde S, Nageris BI, Weiss S, Vahava O, Avraham KB. Clinical characterization of genetic hearing loss caused by a mutation in the POU4F3 transcription factor. Arch Otolaryngol Head Neck Surg. 2000;126(5):633-637.
4. Xiang M, Gao WQ, Hasson T, Shin JJ. Requirement for Brn-3c in maturation and survival, but not in fate determination of inner ear hair cells. Development. 1998;125(20):3935-3946.
5. Xiang M, Maklad A, Pirvola U, Fritzsch B. Brn3c null mutant mice show longterm, incomplete retention of some afferent inner ear innervation. BMC Neurosci. 2003;4(1):2. doi:10.1186/1471-2202-4-2.
6. Xiang M, Gan L, Li D, et al. Essential role of POU-domain factor Brn-3c in auditory and vestibular hair cell development. Proc Natl Acad Sci U S A. 1997;94 (17):9445-9450.
7. Erkman L, McEvilly RJ, Luo L, et al. Role of transcription factors Brn-3.1 and Brn-3.2 in auditory and visual system development. Nature. 1996;381(6583):603-606.
8. Collin RWJ, Chellappa R, Pauw RJ, et al. Missense mutations in POU4F3 cause autosomal dominant hearing impairment DFNA15 and affect tertiary structure, subcellular localization and DNA binding. Hum Mutat. In press.
9. International Organization for Standardization. ISO 7029 Acoustics: Threshold of Hearing by Air Conduction as a Function of Age and Sex for Otologically Normal Persons. Geneva, Switzerland: International Organization for Standardization; 1984.
10. Huygen PLM, Pennings RJE, Cremers CWRJ. Characterizing and distinguishing progressive phenotypes in nonsyndromic autosomal dominant hearing impairment. Audiol Med. 2003;1(1):37-46. doi:10.1080/16513860310003049.
11. Bom SJH, De Leenheer EMR, Lemaire FX, et al. Speech recognition scores related to age and degree of hearing impairment in DFNA2/KCNQ4 and DFNA9/COCH. Arch Otolaryngol Head Neck Surg. 2001;127(9):1045-1048.
12. De Leenheer EMR, Huygen PLM, Coucke PJ, Admiraal RJC, Van Camp G, Cremers CWRJ. Longitudinal and cross-sectional phenotype analysis in a new, large Dutch DFNA2/KCNQ4 family. Ann Otol Rhinol Laryngol. 2002;111(3, pt 1):267-274.
13. Kunst HPM, Huybrechts C, Marres HAM, Huygen PLM, Van Camp G, Cremers CWRJ. The phenotype of DFNA13/COL11A2 : nonsyndromic autosomal dominant mid-frequency and high-frequency sensorineural hearing impairment. Am J Otol. 2000;21(2):181-187.
14. Gottfried I, Huygen PLM, Avraham KB. The clinical presentation of DFNA15/POU4F3. In: Cremers CWRJ, Smith RJH, eds. Genetic Hearing Impairment: Its Clinical Presentations. Basel, Switzerland: S Karger AG; 2002:92-97. Arnold W, ed. Advances in Oto-Rhino-Laryngology; vol 61.
15. De Leenheer EMR, Huygen PLM, Wayne S, Smith RJH, Cremers CWRJ. The DFNA10 phenotype. Ann Otol Rhinol Laryngol. 2001;110(9):861-866.
16. Bischoff AMLC, Pennings RJ, Huygen PLM, et al. Cochleovestibular and ocular features in a Dutch DFNA11 family. Otol Neurotol. 2006;27(3):323-331.
17. Kunst HPM, Marres HAM, Huygen PLM, et al. Non-syndromic autosomal dominant progressive non-specific mid-frequency sensorineural hearing impairment with childhood to late adolescence onset (DFNA21). Clin Otolaryngol Allied Sci. 2000;25(1):45-54.
18. Ensink RJH, Huygen PLM, Snoeckx RL, Caethoven G, Van Camp G, Cremers CWRJ. A Dutch family with progressive autosomal dominant non-syndromic sensorineural hearing impairment linked to DFNA13. Clin Otolaryngol Allied Sci. 2001;26 (4):310-316.
19. Snoeckx RL, Kremer H, Ensink RJH, et al. A novel locus for autosomal dominant non-syndromic hearing loss, DFNA31, maps to chromosome 6p21.3. J Med Genet. 2004;41(1):11-13.
20. Bischoff AMLC, Luijendijk MWJ, Huygen PLM, et al. A novel mutation identified in the DFNA5 gene in a Dutch family: a clinical and genetic evaluation. Audiol Neurootol. 2004;9(1):34-46.
21. Tamagawa Y, Ishikawa K, Ishikawa K, et al. Phenotype of DFNA11: a nonsyndromic hearing loss caused by a myosin VIIA mutation. Laryngoscope. 2002;112(2):292-297.
22. Van Laer L, Pfister M, Thys S, et al. Mice lacking Dfna5 show a diverging number of cochlear fourth row outer hair cells. Neurobiol Dis. 2005;19(3):386-399.
23. Beisel KW, Nelson NC, Delimont DC, Fritzsch B. Longitudinal gradients of KCNQ4 expression in spiral ganglion and cochlear hair cells correlate with progressive hearing loss in DFNA2. Brain Res Mol Brain Res. 2000;82(1-2):137-149.
24. Kubisch C, Schroeder BC, Friedrich T, et al. KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness. Cell. 1999;96(3):437-446.
25. Beisel KW, Rocha-Sanchez SM, Morris KA, et al. Differential expression of KCNQ4 in inner hair cells and sensory neurons is the basis of progressive high-frequency hearing loss. J Neurosci. 2005;25(40):9285-9293.
26. + channels implicate sensory outer hair cells in human progressive deafness. EMBO J. 2006;25(3):642-652.
27. Hasson T, Heintzelman MB, Santos-Sacchi J, Corey DP, Mooseker MS. Expression in cochlea and retina of myosin VIIa, the gene product defective in Usher syndrome type 1B. Proc Natl Acad Sci U S A. 1995;92(21):9815-9819.
28. Bischoff AMLC, Huygen PLM, Kemperman MH, et al. Vestibular deterioration precedes hearing deterioration in the P51S COCH mutation (DFNA9): an analysis in 74 mutation carriers. Otol Neurotol. 2005;26(5):918-925.
29. Kemperman MH, De Leenheer EMR, Huygen PLM, et al. Audiometric, vestibular, and genetic aspects of a DFNA9 family with a G88E COCH mutation. Otol Neurotol. 2005;26(5):926-933.
30. Pauw RJ, Collin RWJ, Huygen PLM, Hoefsloot LH, Kremer H, Cremers CWRJ. Clinical characteristics of a Dutch DFNA9 family with a novel COCH mutation, G87W. Audiol Neurootol. 2007;12(2):77-84.